Literature DB >> 18453667

Needle aponeurotomy for Dupuytren's contracture.

H S Cheng1, L K Hung, W L Tse, P C Ho.   

Abstract

PURPOSE: To review the efficacy and safety of needle aponeurotomy for Dupuytren's contracture in Chinese patients.
METHODS: Seven men and one woman aged 50 to 80 (mean, 67) years underwent needle aponeurotomy for Dupuytren's contracture. Five were manual workers and the other 3 were retired. Their chief complaints were difficulty moving the fingers, clumsiness of the hand, and occasional pain in the palm. No patient had any family history of Dupuytren's contracture.
RESULTS: 41 points were released in 13 fingers (3 middle, 3 ring, and 7 little). Immediately after release, the respective mean flexion contracture correction of the metacarpophalangeal and proximal interphalangeal joints were 50 (from 50 to 0) and 35 (from 46 to 11) degrees. At 22-month follow-up, the respective mean residual flexion contracture of both joints were 12 and 27 degrees; the corresponding long-term improvements were 70 and 41%. No patient had a wound complication or neurovascular injury. All had a normal score for Disabilities of the Arm, Shoulder, and Hand.
CONCLUSION: For Chinese patients with Dupuytren's contracture, needle aponeurotomy is safe and effective. Long-term correction is better maintained in metacarpophalangeal than proximal interphalangeal joints (70 vs 41%).

Entities:  

Mesh:

Year:  2008        PMID: 18453667     DOI: 10.1177/230949900801600120

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN: 1022-5536            Impact factor:   1.118


  10 in total

1.  Molecular mechanisms and treatment strategies for Dupuytren's disease.

Authors:  David B O'Gorman; Linda Vi; Bing Siang Gan
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

2.  Percutaneous fasciotomy for the treatment of Dupuytren's disease-a systematic review.

Authors:  Saoussen Salhi; Etienne Cardin-Langlois; Mario Luc
Journal:  Hand (N Y)       Date:  2011-08-19

Review 3.  Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.

Authors:  Catherine Ball; Anna L Pratt; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2013-04-10       Impact factor: 2.362

4.  The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease.

Authors:  Alexis Thomas; Ardeshir Bayat
Journal:  Ther Clin Risk Manag       Date:  2010-11-04       Impact factor: 2.423

5.  The Re-Emergence of Percutaneous Fasciotomy in the Management of Dupuytren's Disease.

Authors:  James Donaldson; Nicholas Goddard
Journal:  Open Orthop J       Date:  2012-02-23

6.  Clinical Results of Percutaneous Needle Fasciotomy for Dupuytren's Disease in Japanese Patients.

Authors:  Yoshihiro Abe; Susumu Tokunaga
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-06-05

Review 7.  What are we measuring? A critique of range of motion methods currently in use for Dupuytren's disease and recommendations for practice.

Authors:  Anna L Pratt; Catherine Ball
Journal:  BMC Musculoskelet Disord       Date:  2016-01-13       Impact factor: 2.362

8.  Recurrence of Dupuytren's contracture: A consensus-based definition.

Authors:  Hester J Kan; Frank W Verrijp; Steven E R Hovius; Christianne A van Nieuwenhoven; Ruud W Selles
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

9.  Dupuytren's disease and needle aponeurotomy: rupture of a deep common flexor tendon: A case report and literature review.

Authors:  Salma Otayek; Jérôme Pierrart; Emmanuel H Masmejean
Journal:  J Orthop Case Rep       Date:  2016 Jul-Aug

10.  Type-1 Collagen differentially alters beta-catenin accumulation in primary Dupuytren's Disease cord and adjacent palmar fascia cells.

Authors:  Linda Vi; Anna Njarlangattil; Yan Wu; Bing Siang Gan; David B O'Gorman
Journal:  BMC Musculoskelet Disord       Date:  2009-06-19       Impact factor: 2.362

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.